Cargando…
Using referral rates for genetic testing to determine the incidence of a rare disease: The minimal incidence of congenital hyperinsulinism in the UK is 1 in 28,389
Congenital hyperinsulinism (CHI) is a significant cause of hypoglycaemia in neonates and infants with the potential for permanent neurologic injury. Accurate calculations of the incidence of rare diseases such as CHI are important as they inform health care planning and can aid interpretation of gen...
Autores principales: | Yau, Daphne, Laver, Thomas W., Dastamani, Antonia, Senniappan, Senthil, Houghton, Jayne A. L., Shaikh, Guftar, Cheetham, Tim, Mushtaq, Talat, Kapoor, Ritika R., Randell, Tabitha, Ellard, Sian, Shah, Pratik, Banerjee, Indraneel, Flanagan, Sarah E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004321/ https://www.ncbi.nlm.nih.gov/pubmed/32027664 http://dx.doi.org/10.1371/journal.pone.0228417 |
Ejemplares similares
-
Variation in Glycemic Outcomes in Focal Forms of Congenital Hyperinsulinism—The UK Perspective
por: Dastamani, Antonia, et al.
Publicado: (2022) -
Unravelling the genetic causes of mosaic islet morphology in congenital hyperinsulinism
por: Houghton, Jayne AL, et al.
Publicado: (2019) -
Insight into hypoglycemia frequency in congenital hyperinsulinism: evaluation of a large UK CGM dataset
por: Worth, Chris, et al.
Publicado: (2022) -
The hypoglycaemia error grid: A UK-wide consensus on CGM accuracy assessment in hyperinsulinism
por: Worth, Chris, et al.
Publicado: (2022) -
Refinement of the critical genomic region for congenital hyperinsulinism in the Chromosome 9p deletion syndrome
por: Banerjee, Indraneel, et al.
Publicado: (2020)